Cardiovascular Ultrasound Comprehensive Study by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, Other Echocardiograms), Application (Hospitals, Cardiology Centers, Home Care, Ambulatory Centers, Others), Technology (2D, 3D/4D, Doppler), Display (B/W, Color) Players and Region - Global Market Outlook to 2023

Cardiovascular Ultrasound Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Cardiovascular Ultrasound Market Overview:
A Cardiovascular Ultrasound is known as a tool which is used to evaluate the function and structure of the heart and associated vessels. It is easy and fast, a painless evaluation which uses ultrasound waves for producing images of the heart. In North America, the test is been performed by a technologist who is specially trained, called a sonographer, and is interpreted by a physician who is specially-trained, usually, a cardiologist is trained in reading Cardiovascular Ultrasound. Cardiovascular Ultrasound provides the patient's doctor with moving pictures of his heart that allows his doctor to evaluate the heart’s health. Some of the factors like high quality and real-life images produced by 3d cardiovascular ultrasound and benefits associated with cardiovascular ultrasound over conventional methods are driving the market while growing end-user preference for refurbished equipment and the dearth of skilled and well-trained sonographers is challenging the market for its growth.

Market Drivers
  • Increase In the Incidence of Cardiovascular Diseases and Changing Lifestyle
  • High Quality and Real Life Images Produced By 3d Cardiovascular Ultrasound
  • Benefits Associated With Cardiovascular Ultrasound over Conventional Methods

Market Trend
  • Rise in Funding Grants for Product Development

Restraints
  • Stringent Government Rules and Regulations
  • High Cost Associated with Cardiovascular Ultrasound

Opportunities
  • Increase in Demand for Cardiovascular Ultrasound Imaging System in Hospitals
  • Cost Optimization in Manufacturing of Devices

Challenges
  • Growing End-User Preference for Refurbished Equipment
  • Dearth of Skilled and Well-Trained Sonographers


Competitive Landscape:
Product launches help companies in expanding their product ranges and in penetrating various regions to strengthen their market presence. With an increasing number of product approvals and launches in the market, more vendors are focusing on developing next-generation systems for Cardiovascular Ultrasound. It helps vendors sustain intense competition in the market and expand their product portfolio.
Some of the key players profiled in the report are GE Healthcare (United States), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan), SAMSUNG (South Korea), FUJIFILM Holdings (Japan), Esaote (Italy), Shenzhen Mindray Bio-Medical Electronics (China) and Analogic (United States). Considering Market by Technology, the sub-segment i.e. 2D will boost the Cardiovascular Ultrasound market. Considering Market by Display, the sub-segment i.e. B/W will boost the Cardiovascular Ultrasound market.

Market Highlights:
In March 2018, GE Healthcare is a multinational company which provides medical imaging, monitoring, biomanufacturing and cell and gene therapy technologies (US) has expanded with Trice Imaging (US) their partnership for software enhancements and developments to be made for GE’s LOGIQ E10 ultrasound system.

GE Healthcare, had received clearance from the Food and Drug Administration (FDA) for its Vivid T8TM cardiovascular ultrasound device. As per reports, GE had enhanced the reach of the Vivid T8 by combining the established cardiac imaging capabilities of GE Vivid systems with exceptional performance of the company’s LOGIQTM systems

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cardiovascular Ultrasound market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cardiovascular Ultrasound market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Cardiovascular Ultrasound Devices Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Transthoracic Echocardiogram
  • Transesophageal Echocardiogram
  • Stress Echocardiogram
  • Other Echocardiograms
By Application
  • Hospitals
  • Cardiology Centers
  • Home Care
  • Ambulatory Centers
  • Others
By Technology
  • 2D
  • 3D/4D
  • Doppler

By Display
  • B/W
  • Color

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase In the Incidence of Cardiovascular Diseases and Changing Lifestyle
      • 3.2.2. High Quality and Real Life Images Produced By 3d Cardiovascular Ultrasound
      • 3.2.3. Benefits Associated With Cardiovascular Ultrasound over Conventional Methods
    • 3.3. Market Challenges
      • 3.3.1. Growing End-User Preference for Refurbished Equipment
      • 3.3.2. Dearth of Skilled and Well-Trained Sonographers
    • 3.4. Market Trends
      • 3.4.1. Rise in Funding Grants for Product Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Cardiovascular Ultrasound, by Type, Application, Technology, Display and Region (value) (2012-2017)
    • 5.1. Introduction
  • 6. Cardiovascular Ultrasound: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. GE Healthcare (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Philips healthcare (The Netherlands)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Siemens Healthcare (Germany)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Hitachi Medical Corporation (Japan)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Toshiba Medical Systems Corporation (Japan)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. SAMSUNG (South Korea)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. FUJIFILM Holdings (Japan)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Esaote (Italy)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Shenzhen Mindray Bio-Medical Electronics (China)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Analogic (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Cardiovascular Ultrasound Sale, by Type, Application, Technology, Display and Region (value) (2018-2023)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 5. GE Healthcare (United States) Revenue: by Geography 2017
  • Figure 6. Philips healthcare (The Netherlands) Revenue, Net Income and Gross profit
  • Figure 7. Philips healthcare (The Netherlands) Revenue: by Geography 2017
  • Figure 8. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 9. Siemens Healthcare (Germany) Revenue: by Geography 2017
  • Figure 10. Hitachi Medical Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 11. Hitachi Medical Corporation (Japan) Revenue: by Geography 2017
  • Figure 12. Toshiba Medical Systems Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 13. Toshiba Medical Systems Corporation (Japan) Revenue: by Geography 2017
  • Figure 14. SAMSUNG (South Korea) Revenue, Net Income and Gross profit
  • Figure 15. SAMSUNG (South Korea) Revenue: by Geography 2017
  • Figure 16. FUJIFILM Holdings (Japan) Revenue, Net Income and Gross profit
  • Figure 17. FUJIFILM Holdings (Japan) Revenue: by Geography 2017
  • Figure 18. Esaote (Italy) Revenue, Net Income and Gross profit
  • Figure 19. Esaote (Italy) Revenue: by Geography 2017
  • Figure 20. Shenzhen Mindray Bio-Medical Electronics (China) Revenue, Net Income and Gross profit
  • Figure 21. Shenzhen Mindray Bio-Medical Electronics (China) Revenue: by Geography 2017
  • Figure 22. Analogic (United States) Revenue, Net Income and Gross profit
  • Figure 23. Analogic (United States) Revenue: by Geography 2017
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Philips healthcare (The Netherlands)
  • Siemens Healthcare (Germany)
  • Hitachi Medical Corporation (Japan)
  • Toshiba Medical Systems Corporation (Japan)
  • SAMSUNG (South Korea)
  • FUJIFILM Holdings (Japan)
  • Esaote (Italy)
  • Shenzhen Mindray Bio-Medical Electronics (China)
  • Analogic (United States)
Select User Access Type

Key Highlights of Report


Jul 2019 205 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Cardiovascular Ultrasound Market Report?